Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration.

ABSTRACT:

Purpose

To assess the impact of COVID-19-related delay in intravitreal injection timing on macular structure and visual acuity (VA) among patients treated for neovascular age-related macular degeneration (nvAMD).

Methods

We reviewed demographic and clinical data and macular ocular computerized tomographic images of 34 patients (48 eyes, group A) who did not follow their injection schedule during the first wave of COVID-19 and compared them to 46 patients (71 eyes, group B) who did. Functional worsening was defined as a loss of at least 0.1 in decimal VA. Anatomic worsening was defined as new or increased subretinal/intraretinal fluids or new hemorrhage.

Results

The planned mean ± standard deviation intervals between the intravitreal injections were 5.7 ± 2.7 weeks for

SUBMITTER: Hanhart J 

PROVIDER: S-EPMC8747863 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature